327 related articles for article (PubMed ID: 22885158)
1. Novel pectin-based nanoparticles prepared from nanoemulsion templates for improving in vitro dissolution and in vivo absorption of poorly water-soluble drug.
Burapapadh K; Takeuchi H; Sriamornsak P
Eur J Pharm Biopharm; 2012 Oct; 82(2):250-61. PubMed ID: 22885158
[TBL] [Abstract][Full Text] [Related]
2. Potent dried drug nanosuspensions for oral bioavailability enhancement of poorly soluble drugs with pH-dependent solubility.
Mou D; Chen H; Wan J; Xu H; Yang X
Int J Pharm; 2011 Jul; 413(1-2):237-44. PubMed ID: 21540090
[TBL] [Abstract][Full Text] [Related]
3. Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension.
Zhang K; Yu H; Luo Q; Yang S; Lin X; Zhang Y; Tian B; Tang X
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1285-92. PubMed ID: 23562534
[TBL] [Abstract][Full Text] [Related]
4. Nanonization of itraconazole by high pressure homogenization: stabilizer optimization and effect of particle size on oral absorption.
Sun W; Mao S; Shi Y; Li LC; Fang L
J Pharm Sci; 2011 Aug; 100(8):3365-3373. PubMed ID: 21520089
[TBL] [Abstract][Full Text] [Related]
5. Enhanced pulmonary absorption of poorly soluble itraconazole by micronized cocrystal dry powder formulations.
Karashima M; Sano N; Yamamoto S; Arai Y; Yamamoto K; Amano N; Ikeda Y
Eur J Pharm Biopharm; 2017 Jun; 115():65-72. PubMed ID: 28223260
[TBL] [Abstract][Full Text] [Related]
6. Dry powder inhaler formulations of poorly water-soluble itraconazole: A balance between in-vitro dissolution and in-vivo distribution is necessary.
Huang Z; Lin L; McGoverin C; Liu H; Wang L; Zhou QT; Lu M; Wu C
Int J Pharm; 2018 Nov; 551(1-2):103-110. PubMed ID: 30217767
[TBL] [Abstract][Full Text] [Related]
7. Development and evaluation of novel itraconazole-loaded intravenous nanoparticles.
Chen W; Gu B; Wang H; Pan J; Lu W; Hou H
Int J Pharm; 2008 Oct; 362(1-2):133-40. PubMed ID: 18585448
[TBL] [Abstract][Full Text] [Related]
8. Enhancing the stability of oil-in-water emulsion using pectin-lactoferrin complexes.
Yuliarti O; Lau ZX; Wee L; Kwan CKJ
Int J Biol Macromol; 2019 Oct; 139():421-430. PubMed ID: 31374276
[TBL] [Abstract][Full Text] [Related]
9. Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties.
Duret C; Wauthoz N; Sebti T; Vanderbist F; Amighi K
Int J Pharm; 2012 May; 428(1-2):103-13. PubMed ID: 22414388
[TBL] [Abstract][Full Text] [Related]
10. Parenteral nanoemulsions as promising carriers for brain delivery of risperidone: Design, characterization and in vivo pharmacokinetic evaluation.
Đorđević SM; Cekić ND; Savić MM; Isailović TM; Ranđelović DV; Marković BD; Savić SR; Timić Stamenić T; Daniels R; Savić SD
Int J Pharm; 2015 Sep; 493(1-2):40-54. PubMed ID: 26209070
[TBL] [Abstract][Full Text] [Related]
11. Development of stabilized itraconazole nanodispersions by using high-gravity technique.
Zhang ZL; Le Y; Wang JX; Zhao H; Chen JF
Drug Dev Ind Pharm; 2012 Dec; 38(12):1512-20. PubMed ID: 22435399
[TBL] [Abstract][Full Text] [Related]
12. Nebulized oil-in-water nanoemulsion mists for pulmonary delivery: development, physico-chemical characterization and in vitro evaluation.
Nesamony J; Shah IS; Kalra A; Jung R
Drug Dev Ind Pharm; 2014 Sep; 40(9):1253-63. PubMed ID: 23837519
[TBL] [Abstract][Full Text] [Related]
13. Formulation and characterization of biocompatible and stable I.V. itraconazole nanosuspensions stabilized by a new stabilizer polyethylene glycol-poly(β-Benzyl-l-aspartate) (PEG-PBLA).
Zong L; Li X; Wang H; Cao Y; Yin L; Li M; Wei Z; Chen D; Pu X; Han J
Int J Pharm; 2017 Oct; 531(1):108-117. PubMed ID: 28830781
[TBL] [Abstract][Full Text] [Related]
14. Nanoemulsions as vehicles for transdermal delivery of aceclofenac.
Shakeel F; Baboota S; Ahuja A; Ali J; Aqil M; Shafiq S
AAPS PharmSciTech; 2007 Dec; 8(4):E104. PubMed ID: 18181525
[TBL] [Abstract][Full Text] [Related]
15. Oil based nanocarrier for improved oral delivery of silymarin: In vitro and in vivo studies.
Parveen R; Baboota S; Ali J; Ahuja A; Vasudev SS; Ahmad S
Int J Pharm; 2011 Jul; 413(1-2):245-53. PubMed ID: 21549187
[TBL] [Abstract][Full Text] [Related]
16. A new self-emulsifying formulation of itraconazole with improved dissolution and oral absorption.
Hong JY; Kim JK; Song YK; Park JS; Kim CK
J Control Release; 2006 Jan; 110(2):332-338. PubMed ID: 16297483
[TBL] [Abstract][Full Text] [Related]
17. Flocculated amorphous itraconazole nanoparticles for enhanced in vitro supersaturation and in vivo bioavailability.
Miller MA; DiNunzio J; Matteucci ME; Ludher BS; Williams RO; Johnston KP
Drug Dev Ind Pharm; 2012 May; 38(5):557-70. PubMed ID: 21961961
[TBL] [Abstract][Full Text] [Related]
18. In Vitro and In Vivo Characterization of Drug Nanoparticles Prepared Using PureNano™ Continuous Crystallizer to Improve the Bioavailability of Poorly Water Soluble Drugs.
Tahara K; Nishikawa M; Matsui K; Hisazumi K; Onodera R; Tozuka Y; Takeuchi H
Pharm Res; 2016 Sep; 33(9):2259-68. PubMed ID: 27301372
[TBL] [Abstract][Full Text] [Related]
19. Self-nanoemulsifying drug delivery system (SNEDDS) of the poorly water-soluble grapefruit flavonoid Naringenin: design, characterization, in vitro and in vivo evaluation.
Khan AW; Kotta S; Ansari SH; Sharma RK; Ali J
Drug Deliv; 2015; 22(4):552-61. PubMed ID: 24512268
[TBL] [Abstract][Full Text] [Related]
20. Characterization and pharmacokinetic study of itraconazole solid dispersions prepared by solvent-controlled precipitation and spray-dry methods.
Sim T; Lim C; Lee JW; Kim DW; Kim Y; Kim M; Choi S; Choi HG; Lee ES; Kim KS; Kang W; Oh KT
J Pharm Pharmacol; 2017 Dec; 69(12):1707-1715. PubMed ID: 28872678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
